Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)

Camp4 Therapeutics has disclosed Research & Development across 4 years of filings, most recently posting $10.2 million for Q1 2026.

• Research & Development for Q1 2026 came in at $10.2 million, changed 0.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $214000.0 (down 99.45% YoY), and the FY2025 annual result was $200000.0, down 99.48% from the prior year.
• Research & Development came in at $10.2 million for Q1 2026 at Camp4 Therapeutics, up from -$29.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $10.7 million in Q4 2023 to a low of -$29.6 million in Q4 2025.
• The 4-year median for Research & Development is $9.8 million (2023), against an average of $6.3 million.
• Peak annual rise in Research & Development reached 10.16% in 2025, while the deepest fall reached 396.57% in 2025.
• Camp4 Therapeutics' Research & Development stood at $10.7 million in 2023, then dropped by 6.24% to $10.0 million in 2024, then slumped by 396.57% to -$29.6 million in 2025, then surged by 134.27% to $10.2 million in 2026.
• The last three Research & Development figures came in at $10.2 million (Q1 2026), -$29.6 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.